First Report of Human Pancreas Transplantation Using IGL-1 Preservation Solution: A Case Series

Transplantation. 2016 Sep;100(9):e46-7. doi: 10.1097/TP.0000000000001242.

Authors

Marcio F Chedid¹, Tomaz J M Grezzana-Filho, Rosangela M Montenegro, Ian Leipnitz, Riad A Hadi, Aljamir D Chedid, Cleber R P Kruel, Adriana R Ribeiro, Juliano B Gressler, Nancy T Denicol, Cleber D P Kruel, Roberto C Manfro

Affiliation

¹ 1 Liver and Pancreas Transplant and Hepatobiliary Surgery Unit, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul (RS), Brazil. 2 Division of Nephrology and Kidney Transplantation Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul (RS), Brazil. 3 Division of Urology, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul (RS), Brazil.

PMID: 27163542
DOI: 10.1097/TP.0000000000001242

No abstract available

Publication types

Letter

MeSH terms

Adult
Cold Ischemia
Delayed Graft Function / etiology
Female
Graft Rejection / immunology
Humans
Kidney Transplantation / adverse effects
Kidney Transplantation / methods*
Kidney Transplantation / mortality
Male
Middle Aged
Organ Preservation / adverse effects
Organ Preservation / methods*
Organ Preservation / mortality
Organ Preservation Solutions / adverse effects
Organ Preservation Solutions / therapeutic use*
Pancreas Transplantation / adverse effects
Pancreas Transplantation / methods*
Pancreas Transplantation / mortality
Time Factors
Treatment Outcome
Young Adult

Substances

IGL-1 solution
Organ Preservation Solutions